Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changes in plasma fibronectin levels in thyroid diseases.

A Shirakami, Y Hirai, T Takeichi

    Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Second national external quality assessment scheme in hematology: the Philippine experience.

    The Southeast Asian journal of tropical medicine and public health·2003
    Same author

    Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes.

    Diabetologia·2003
    Same author

    Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes.

    The Journal of endocrinology·2002
    Same author

    Involvement of bradykinin in acute exercise-induced increase of glucose uptake and GLUT-4 translocation in skeletal muscle: studies in normal and diabetic humans and rats.

    Metabolism: clinical and experimental·2000
    Same author

    Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways.

    Diabetes research and clinical practice·2000
    Same author

    Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.

    Diabetologia·1998

    Plasma fibronectin (Fn) levels differ in thyroid conditions, being high in hyperthyroidism and low in hypothyroidism. Fn levels normalize with treatment, correlating with thyroid hormone levels, indicating altered Fn metabolism in thyroid disease.

    Area of Science:

    • Endocrinology
    • Biochemistry
    • Clinical Medicine

    Background:

    • Fibronectin (Fn) is a glycoprotein involved in cell adhesion and tissue repair.
    • Thyroid hormones play a crucial role in regulating metabolism.

    Purpose of the Study:

    • To investigate plasma fibronectin levels in patients with various thyroid diseases.
    • To explore the relationship between fibronectin levels and thyroid function.
    • To assess the utility of plasma fibronectin as a marker for monitoring thyroid disease treatment.

    Main Methods:

    • Plasma fibronectin levels were measured in normal subjects and patients with hyperthyroidism, hypothyroidism, and simple goiter.
    • Correlation analysis was performed between fibronectin levels and serum triiodothyronine (T3) and thyroxine (T4) levels.

    Related Experiment Videos

  • Changes in fibronectin levels were monitored during anti-thyroid drug treatment.
  • Main Results:

    • Plasma Fn levels were significantly elevated in hyperthyroidism (62.6 mg/dl) and decreased in hypothyroidism (19.2 mg/dl) compared to normal subjects (32.0 mg/dl).
    • Patients with simple goiter showed normal plasma Fn levels (29.1 mg/dl).
    • Plasma Fn levels normalized with anti-thyroid treatment, correlating with improved thyroid function and normalized T3 and T4 levels.

    Conclusions:

    • Plasma fibronectin levels are altered in thyroid diseases, reflecting changes in fibronectin metabolism.
    • Plasma Fn measurement can serve as a biomarker for assessing thyroid dysfunction and monitoring treatment efficacy.